Pyridostigmine Bromide Tablets USP — Class II drug recall D-1079-2014
Terminated recall by Corepharma LLC, reported 2014-02-12, distributed nationwide. Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to
| Recall number | D-1079-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Corepharma LLC, Middlesex, NJ, United States |
| Recall initiated | 2013-12-13 |
| Classified | 2014-02-05 |
| Reported by FDA | 2014-02-12 |
| Terminated | 2015-01-29 |
| Distributed | Nationwide (US) |
| Quantity | 174,888 bottles |
| Reason classes | specification failure |
| NDC | 64720-0128-10 |
| Lot numbers | 106019, 106020, DECEMBER-13 |
Product
Pyridostigmine Bromide Tablets USP, 60 mg, 100 count bottle, Rx only, Manufactured and Distributed by: Corepharma, LLC Middlesex, NJ 08846, NDC 64720-128-10
Reason for recall
Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the 30 month stability time point.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1079-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.